 | Monter d'un niveau |
Karengera, E., Durocher, Y., De Crescenzo, G., & Henry, O. (2017). Combining metabolic and process engineering strategies to improve recombinant glycoprotein production and quality. Applied Microbiology and Biotechnology, 101(21), 7837-7851. Lien externe
Karengera, E., Robotham, A., Kelly, J., Durocher, Y., De Crescenzo, G., & Henry, O. (2017). Altering the central carbon metabolism of HEK293 cells: Impact on recombinant glycoprotein quality. Journal of Biotechnology, 242, 73-82. Lien externe
Riahi, N., Liberelle, B., Henry, O., & De Crescenzo, G. (2017). Impact of RGD amount in dextran-based hydrogels for cell delivery. Carbohydrate Polymers, 161, 219-227. Lien externe
Riahi, N., Murschel, F., Lerouge, S., Durocher, Y., Henry, O., & De Crescenzo, G. (2017). Bioavailability of immobilized epidermal growth factor: Covalent versus noncovalent grafting. Biointerphases, 12(1), 010501 (8 pages). Lien externe
Venereo-Sanchez, A., Simoneau, M., Lanthier, S., Chahal, P., Bourget, L., Ansorge, S., Gilbert, R., Henry, O., & Kamen, A. (2017). Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line. Vaccine, 35(33), 4220-4228. Lien externe
